Mission & Vision

Since 2nd May 2022

Your Healthcare Partner

Who We Are

Gavalis Healthcare is an Indian origin multinational pharmaceutical Company engaged in selling and distributing advanced, high quality and affordable drugs & devices in Renal and Critical care domain in India.

The company is uniquely positioned with a first-mover advantage, which allows for it to quickly create a portfolio of differentiated global assets in emerging markets.

ABOUT INDUSTRY

We design and build innovative platforms for inspiring brand

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters.

Gavalis Healthcare is Best Company

We design and build innovative platforms for inspiring brand

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters.

Our Expertise

Strong Foothold

Organization have strong foothold in all the major corporate Hospital chains, Standalone Hospitals and all the central and State Government Institutions.

Company

Company is equipped with robust logistic capabilities with 3 fully owned and automated storage locations to manage the entire distribution cycle and trading across all the institute within the country.

Organization

Organization is having the trained manpower of 43 having expertise in handling the high value and first of its kind of therapies.

Specialities

At Gavalis Healthcare, we focus on bringing hitherto unavailable novel medicines, devices, molecular diagnostics reno-protective, extracorporeal devices and Novel critical care therapies

Commercialization